Lucinda A. Harris, M.D.

  1. Internist
  2. Gastroenterologist

Location

  1. Phoenix, Arizona

Languages

English
  1. Celiac disease
  2. Gastrointestinal disorder
  3. GERD
  4. Irritable bowel syndrome
  • Irritable bowel syndrome
  • Gastrointestinal motility disorders
  • Gastroesophageal reflux disease
  • Celiac disease (sprue)
  • Women's health issues in GI
  1. 1989
    Fellow - Department of Medicine - Division of Digestive DiseasesCornell University Medical College
  2. 1986
    Resident - Department of MedicineNew York Presbyterian Hospital, College of Physicians and Surgeons, Columbia University, New York, NY
  3. 1983
    MDUniversity of Connecticut School of Medicine
  4. 1979
    MS - Community HealthUniversity of Connecticut
  5. 1976
    BA - BiochemistryBarnard College

Certifications

  1. 1993
    GastroenterologyAmerican Board of Internal Medicine
  2. 1987
    Internal MedicineAmerican Board of Internal Medicine

Awards and honors

  1. 2013
    Excellence in Clinical Practice Writer's AwardSociety of Gastroenterology Nurses and Associates, Inc.
  2. 1971
    Honors GroupWestinghouse Science Talent Search
  3.  
    Scholars in Medicine ProgramUniversity of Connecticut School of Medicine
  4.  
    American Medical Women's Association GrantAmerican Medical Women's Association

Professional memberships

  1. 2013
    Co-DirectorMotility, Division of Gastroenterology, Department of Internal Medicine
  2. 2013 - present
    FellowAmerican Gastroenterological Association
  3. 2012
    ConsultantTakeda Pharmaceuticals
  4. 2009
    Co-DirectorMotility, Division of Gastroenterology, Department of Internal Medicine
  5. 2009
    ConsultantProcter & Gamble
  6. 2009
    ConsultantSalix Pharmaceuticals, Inc.
  7. 2009 - present
    MemberAmerican Society for Gastrointestinal Endoscopy
  8. 2008 - 2010
    ConsultantTakeda Pharmaceuticals
  9. 2008
    ConsultantPrometheus Laboratories
  10. 2008 - present
    ConsultantIronwood Pharmaceuticals
  11. 2007
    ReviewerFunctional Abstracts for October 2007 Meeting, American College of Gastroenterology
  12. 2007
    MemberWomen in Gastroenterology Committee, American College of Gastroenterology
  13. 2007 - present
    Advisory Board MemberInternational Foundation for Functional Gastrointestinal Disorders
  14. 2006 - 2008
    MemberGastrointestinal Events Research Board, Renzapride-Quintiles, Inc.
  15. 2006
    MemberSelection Committee for Chairman, Division of Gastroenterology, Department of Internal Medicine
  16. 2006 - present
    MemberEducation Committee, Gastroenterology Fellowship, Division of Gastroenterology
  17. 2006 - present
    MemberGastroenterology Task Force of the Mayo Pharmaceutical Formulary Committee, Division of Gastroenterology, Department of Internal Medicine
  18. 2006 - present
    Department Education CoordinatorDivision of Gastroenterology, Department of Internal Medicine
  19. 2006 - present
    MemberDigestive Center for Women Network
  20. 2005 - present
    MemberAmerican Motility Society
  21. 2004 - 2006
    Co-DirectorIrritable Bowel Syndrome Patient Support Group, Mayo Clinic Arizona Task Forces
  22. 2004 - 2006
    Co-DirectorIrritable Bowel Syndrome Patient Support Group, Division of Gastroenterology, Department of Internal Medicine
  23. 2004 - 2006
    MemberIrritable Bowel Syndrome Patient Support Group, Mayo Clinic Arizona Task Forces
  24. 2004 - present
    Co-AdvisorJournal Club, Division of Gastroenterology, Department of Internal Medicine
  25. 2004 - present
    MemberJournal Club, Division of Gastroenterology, Department of Internal Medicine
  26. 2003
    MemberAdvisory Board, American Pharmaceutical Association
  27. 2003
    MemberGastrointestinal Advisory Board on Irritable Bowel Syndrome, Solway Pharmaceutical Co.
  28. 2003
    MemberConsultancy Network - Zelnorm, Novartis Pharmaceuticals
  29. 2002 - 2003
    MemberGastrointestinal Advisory Board - Talnetant for Irritable Bowel Syndrome, GlaxoSmithKline
  30. 2002
    MemberGastrointestinal Advisory Board - Alosetron, GlaxoSmithKline
  31. 2002
    MemberGastrointestinal Advisory Board - Zelnorm Efficacy & Safety, Novartis Pharmaceuticals
  32. 2002
    MemberReintroduction of Lotronex, GlaxoSmithKline
  33. 2002 - present
    FellowAmerican College of Physicians
  34. 2002 - present
    MemberFunctional Brain-Gut Research Group
  35. 2001
    MemberGastrointestinal Advisory Board on Irritable Bowel Syndrome & Zelnorm, RuderFinn, Inc.
  36. 2001
    MemberGastrointestinal National Advisory Board, GlaxoSmithKline
  37. 2001
    MemberAdvisory Board on Cilansetron, Solway Pharmaceutical Co.
  38. 2001 - present
    MemberAmerican College of Gastroenterology
  39. 2001 - present
    MemberInternational Foundation for Functional Gastrointestinal Disorders
  40. 2000 - 2006
    EditorGastroenterology Section, praxismd.com (Website for physicians and patients) evolved to Micromedex
  41. 2000 - 2001
    MemberIrritable Bowel Syndrome National Advisory Board, Glaxo Wellcome, Inc.
  42. 2000
    Group LeaderIrritable Bowel Syndrome Regional Advisory Board, Glaxo Wellcome, Inc.
  43. 2000
    MemberLaunch of Lotronex Consultants Meeting, Glaxo Wellcome, Inc.
  44. 2000
    MemberIrritable Bowel Syndrome National Advisory Board, Novartis Pharmaceuticals
  45. 2000
    MemberGlobal Telegenetics Medical Group
  46. 2000
    MemberLotronex to the FDA, Glaxo Wellcome, Inc.
  47. 1999 - 2004
    MemberFormulary and Therapeutics Committee, New York Presbyterian Hospital
  48. 1999 - 2004
    MemberGerson Lehrman Financial Group
  49. 1999 - 2003
    MemberAmerican Liver Foundation
  50. 1999 - 2000
    MemberIrritable Bowel Syndrome Regional Advisory Board, Glaxo Wellcome, Inc.
  51. 1999
    ConsultantIrritable Bowel Syndrome Regional Advisory Board, Glaxo Wellcome, Inc.
  52. 1990 - present
    MemberCrohn's and Colitis Foundation of America
  53. 1989 - present
    MemberAmerican College of Physicians
  54. 1988 - present
    MemberNew York Society of Gastrointestinal Endoscopy
  55. 1987 - present
    MemberAmerican Gastroenterological Association
  56. 1979 - present
    MemberAmerican Medical Women's Association
  57.  
    MemberGI Fellowship, Education Committee, Division of Gastroenterology
  58.  
    FellowAmerican College of Gastroenterology
  59.  
    ConsultantIrritable Bowel Syndrome National Advisory Board, Novartis Pharmaceuticals
  60.  
    ConsultantIrritable Bowel Syndrome National Advisory Board, Glaxo Wellcome, Inc.
  61.  
    ConsultantGastrointestinal Advisory Board on Irritable Bowel Syndrome & Zelnorm, RuderFinn, Inc.
  62.  
    ConsultantGastrointestinal National Advisory Board, GlaxoSmithKline
  63.  
    ConsultantGastrointestinal Advisory Board - Alosetron, GlaxoSmithKline
  64.  
    ConsultantGastrointestinal Advisory Board - Zelnorm Efficacy & Safety, Novartis Pharmaceuticals
  65.  
    ConsultantReintroduction of Lotronex, GlaxoSmithKline
  66.  
    ConsultantGastrointestinal Advisory Board - Talnetant for Irritable Bowel Syndrome, GlaxoSmithKline
  67.  
    ConsultantGastrointestinal Advisory Board on Irritable Bowel Syndrome, Solway Pharmaceutical Co.
  68.  
    ConsultantGerson Lehrman Financial Group
  69.  
    ConsultantGastroenterology, Global Telegenetics Medical Group
  70.  
    Clinical ConsultantAdvisory Board on Cilansetron, Solway Pharmaceutical Co.
  71.  
    Clinical ConsultantLotronex to the FDA, Glaxo Wellcome, Inc.
  72.  
    ConsultantGastrointestinal Events Research Board, Renzapride-Quintiles, Inc.
  73.  
    MemberZelnorm, New Product Bulletin, Advisory Board
See more

Publications

Research activities

See a description of research activities.